Real-World Experience With Apremilast in the Treatment of Adults With Moderate to Severe Plaque Psoriasis in Québec: A Claims-Based Analysis of Drug Utilization and Healthcare Resource Utilization.
Yves PoulinCatherine BeaucheminCatherine RoyerAnne-Julie GaudreauClarabella YimFei Fei LiuLachaine JeanPublished in: Journal of cutaneous medicine and surgery (2020)
Adding apremilast to the drug formulary of other Canadian provinces could result in significant healthcare savings.